
Ivermectin Litigation is Forcing Judges to Make Medical Decisions for COVID-19 Patients
Courts across the country have allowed hospitals to let COVID-19 patients undergo treatment with Ivermectin. Courts are overruling the warning that the Food and Drug Administration, the Centers for Disease Control and Prevention, the World Health Organization and the American Medical Association have issued against using the drug to treat COVID-19. The use of the unregulated drug has caused many lawsuits to emerge, and is generating concern among health-care lawyers.
“You could have just tried something else and chose not to,” Davis Goldman Partner Aaron Davis told Daily Business Review. “There’s a reason why standards of care are developed and why certain agencies approve medication, and it’s because they go through a series of testing and safety profiles.”
Latest Posts
Davis Goldman attorneys recognized in Lawdragon’s 500 Leading Litigators in America
Davis Goldman is proud to have four of our attorneys recognized for the second consecutive year in Lawdragon’s 500 Leading Litigators in America!...
Florida’s Tort Reform Law Already Impacting Healthcare Providers
Six months after Florida’s Tort Reform Law went into effect, it has not enticed insurers back to Florida or lowered premiums the way legislators said it...
Jason Goldman Recognized in 30th Edition of ‘The Best Lawyers in America’
Davis Goldman Co-Managing Partner Jason Goldman is recognized as a ‘Best Lawyer’ in the 30th Edition of ‘The Best Lawyers in America’!